3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
9
Non-metastatic Castration-resistant Prostate Cancer
2
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
2
Salivary Gland Neoplasms
1
Refractory or Relapsed Solid Tumors
1
Metastatic Castration-resistant Prostate Neoplasms
1
Metastatic Castration-resistant Prostate Cancer
1
High-Risk Localized Prostate Cancer
1
Granulosa cell tumor of the ovary
1
Bulbo-Spinal Atrophy, X-Linked
1
Biochemically Recurrent Prostate Cancer
1
Adenocarcinoma
1
Interventions
pembrolizumab
3
tislelizumab
2
Injections
2
toripalimab
1
atezolizumab
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Fulvestrant
1
Drug Therapy
1
Antineoplastic Agents
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Advanced Solid Tumor
×
darolutamide
×
30 days
×
Clear all
No trials found.